Back to mobile site

Revance Therapeutic (RVNC) PT Lowered to $16 at Mizuho Securities

November 22, 2023 6:32 AM EST
Get Alerts RVNC Hot Sheet
Price: $3.65 --0%

Rating Summary:
    4 Buy, 14 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Mizuho Securities analyst Vamil Divan lowered the price target on Revance Therapeutic (NASDAQ: RVNC) to $16.00 (from $35.00) while maintaining a Buy rating.

You May Also Be Interested In





Related Categories

Analyst PT Change